Post by Barbara W. Unger | August 9, 2019

Part 2: Analysis of CY2018 FDA Warning Letters That Cite Data Integrity Failures

The second and final part of this report will cover the actions firms can take to prevent, identify, and remediate issues as well as summarizing the trends of data integrity failures.